Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

Psoriasis Induced by Infliximab in a Patient Suffering from Crohn's Disease

(2017) E. Manni et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Learning the Lessons of Antitumour Necrosis Factor Therapy-Associated Psoriasis

(2016) Matt Shale et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab

(2015) Penny Lovell English et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab

(2010) F. Medkour et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Review article: anti TNF-α induced psoriasis in patients with inflammatory bowel disease

(2009) G. FIORINO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

(2009) Uwe Wollina et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

First Case Report of Adalimumab-Induced Psoriasis in Crohn's Disease

(2009) Michael D Harris et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockers

(2009) Laila El Shabrawi-Caelen et al.   INFLAMMATORY BOWEL DISEASES

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

(2008) Angelique N. Collamer et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor antagonist mechanisms of action: A comprehensive review

(2007) Daniel Tracey et al.   PHARMACOLOGY & THERAPEUTICS